Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Ltd

₹ 2,452 0.33%
23 Feb 4:01 p.m.
About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

Key Points

About[1]
It is the largest diagnostics chain with a PAN India presence and a consistent track record of quality and growth. The company has 70+ yrs of experience in the field of diagnostics. The company has serviced 111 Mn+ patients
in the last 5 years.

  • Market Cap 20,453 Cr.
  • Current Price 2,452
  • High / Low 2,767 / 1,762
  • Stock P/E 62.0
  • Book Value 212
  • Dividend Yield 0.74 %
  • ROCE 18.2 %
  • ROE 15.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 35.7%

Cons

  • Stock is trading at 11.6 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
452 431 607 498 497 486 503 534 489 491 541 601 539
314 309 418 357 388 364 385 390 376 375 395 424 398
Operating Profit 139 122 189 142 109 121 118 144 113 116 146 178 141
OPM % 31% 28% 31% 28% 22% 25% 23% 27% 23% 24% 27% 30% 26%
14 14 14 14 12 12 8 9 10 14 14 18 18
Interest 4 4 5 5 9 12 8 11 9 9 8 8 7
Depreciation 20 20 19 20 31 38 36 39 38 38 35 36 36
Profit before tax 129 111 179 131 82 84 81 103 76 83 118 152 116
Tax % 26% 23% 25% 26% 29% 26% 28% 30% 30% 32% 29% 27% 29%
96 85 134 96 58 62 58 72 54 57 84 111 82
EPS in Rs 11.34 10.01 15.74 11.40 6.88 7.35 6.92 8.60 6.33 6.80 9.90 13.09 9.74
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
342 452 558 660 791 912 1,057 1,203 1,330 1,581 2,087 2,017 2,172
256 354 419 504 582 675 793 910 987 1,145 1,526 1,527 1,592
Operating Profit 87 98 139 156 210 238 264 294 344 436 561 490 580
OPM % 25% 22% 25% 24% 26% 26% 25% 24% 26% 28% 27% 24% 27%
2 3 8 12 20 27 31 46 55 51 52 42 65
Interest 3 0 0 0 0 1 1 1 15 16 30 38 32
Depreciation 20 20 27 28 28 28 33 38 73 77 108 150 145
Profit before tax 66 80 119 140 201 237 261 301 310 394 475 344 469
Tax % 32% 31% 33% 31% 34% 34% 34% 33% 27% 25% 26% 30%
45 55 80 96 133 156 172 200 228 296 350 241 333
EPS in Rs 1,333.04 1,643.22 148.27 17.51 15.99 18.61 20.49 23.90 27.11 34.99 41.37 28.65 39.53
Dividend Payout % 19% 9% 7% 9% 15% 16% 22% 25% 44% 57% 29% 21%
Compounded Sales Growth
10 Years: 16%
5 Years: 14%
3 Years: 15%
TTM: 8%
Compounded Profit Growth
10 Years: 16%
5 Years: 7%
3 Years: 2%
TTM: 35%
Stock Price CAGR
10 Years: %
5 Years: 19%
3 Years: 2%
1 Year: 28%
Return on Equity
10 Years: 24%
5 Years: 22%
3 Years: 21%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3 3 54 55 83 83 83 83 83 83 83 83 84
Reserves 111 157 151 260 425 512 705 862 949 1,162 1,418 1,583 1,689
Preference Capital 2 2 27 27 0 0 0 0 0 0 0 0
0 0 1 0 0 0 0 0 0 150 532 420 299
63 108 146 161 118 95 128 145 341 265 309 297 374
Total Liabilities 177 269 352 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,445
108 127 140 150 166 152 208 209 413 447 1,369 1,305 1,259
CWIP 6 1 0 1 4 18 10 3 11 10 15 5 10
Investments 5 55 9 38 64 106 145 185 164 59 65 150 110
58 87 203 286 391 414 554 694 786 1,144 893 923 1,066
Total Assets 177 269 352 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,445

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
68 88 98 122 159 171 197 219 284 398 447 456
-26 -64 -89 -113 -163 -137 -172 -100 -26 -212 -449 -287
-38 -15 -10 -1 0 -32 13 -55 -190 -139 136 -283
Net Cash Flow 4 9 -2 8 -5 2 37 64 67 48 134 -114

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 15 16 16 17 17 17 14 16 14 15 15 13
Inventory Days 37 31 33 44 40 70 39 38 28
Days Payable 90 89 97 106 111 144 132 107 127
Cash Conversion Cycle 15 16 16 -35 -42 -47 -47 -55 -60 -78 -54 -87
Working Capital Days -27 -39 -26 -9 27 19 17 0 -19 -17 -14 -19
ROCE % 60% 58% 60% 48% 47% 43% 38% 35% 32% 33% 29% 18%

Shareholding Pattern

Numbers in percentages

20 Recently
Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
55.23% 55.23% 55.23% 55.23% 55.23% 55.05% 55.04% 55.04% 55.03% 55.01% 54.61% 54.60%
26.01% 26.42% 26.82% 25.45% 23.44% 22.37% 23.26% 25.80% 24.89% 23.27% 24.35% 25.36%
7.52% 6.54% 5.73% 6.57% 6.83% 6.52% 6.27% 6.20% 6.56% 8.34% 8.85% 9.27%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.29% 0.29% 0.29%
10.37% 10.96% 11.42% 12.01% 13.80% 15.46% 14.84% 12.38% 13.01% 12.65% 11.48% 10.12%
0.87% 0.85% 0.80% 0.74% 0.70% 0.60% 0.58% 0.56% 0.51% 0.44% 0.41% 0.37%
No. of Shareholders 68,84594,1231,25,9531,35,0681,71,8461,84,5081,71,6021,79,6361,80,1631,74,4441,60,6791,49,901

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls